Home・Elenco Azioni・Medpace Holdings Inc

Medpace Holdings Inc

Chiusa

SettoreSettore sanitario

605.28 0.86

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

587.22

Massimo

602.69

Metriche Chiave
By Trading Economics
Entrata	-2.5M 121M
Vendite	727K 707M
P/E Media del settore	33.683 68.51
EPS	4.25
Margine di Profitto	17.158
Dipendenti	6,500
EBITDA	-21M 134M

Raccomandazioni
By TipRanks
Raccomandazioni	Neutrale
Previsioni per 12 mesi	-3.69% downside

Dividendi
By Acuity
Utili prossimi	21 ott 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	924M 16B
Apertura precedente	604.42
Chiusura precedente	605.28

Notizie sul Sentiment di mercato

By Acuity

50%

128 / 340 Classifica in Healthcare

Medpace Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 ago 2026, 19:16 UTC

Medpace Holdings Inc. shares are lower today, reflecting a slight pullback amid broader market factors, including economic signals and geopolitical tensions.

3 ago 2026, 19:26 UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

30 lug 2026, 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

29 lug 2026, 18:44 UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

28 lug 2026, 23:11 UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

27 lug 2026, 16:56 UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24 lug 2026, 18:26 UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22 lug 2026, 23:22 UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21 lug 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Confronto tra pari

Modifica del prezzo

Medpace Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

-3.69% in calo

Previsioni per 12 mesi

Media 580.2 USD -3.69%

Alto 692 USD

Basso 450 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Medpace Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

11 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 11 che hanno fornito valutazioni azionarie a Medpace Holdings Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

128 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.